Farms.com Home   News

Brooke Rollins confirmed as Donald Trump’s agriculture secretary as tariff fights loom

Conservative lawyer Brooke Rollins was confirmed Thursday as secretary of agriculture, placing a close ally of President Donald Trump into a key Cabinet position at a time when mass deportation plans could lead to farm labour shortages and tariffs could hit agricultural exports.

Rollins, who served as chief for domestic policy during Trump’s first administration, was confirmed overwhelmingly by the Senate in a 72-28 vote.

Rollins will now lead a department tasked with overseeing nearly all aspects of the nation’s food system, including standards on farming practices and livestock rearing, federal subsidies to farmers or agribusinesses and setting nutrition standards for schools and public health officials nationwide.

The Department of Agriculture was at the centre of Trump’s trade war in his last administration, when it increased subsidies to farmers growing the nation’s two biggest crops, corn and soybeans, after retaliatory tariffs were levied by China on the grains and international markets were disrupted. The United States is the world’s largest food exporter.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.